DaShenLin Pharmaceutical Group Co., Ltd.SSE: 603233

(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Change of Relevant Commitments by the Controlling Shareholder and Actual Controller

· Issued by DaShenLin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603233 · · 4 pages · Chinese

Summary by 6ix AI

DaShenLin Pharmaceutical Group Co., Ltd. has announced a change in commitments by its controlling shareholder and actual controller regarding leased properties. The company received a letter proposing changes to previous commitments due to operational needs, which were approved in a recent board meeting. The original commitments were extended to address property ownership issues that have not yet been resolved. The changes aim to ensure the company's operational stability and protect shareholder interests.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603233dashenlin-pharmaceutical-group-co-ltdannouncement-on-change-of-relevant-commitments-by-the-controlling-shareholder-and-actual-controller

Release

Announcement on Change of Relevant Commitments by the Controlling Shareholder and Actual Controller
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:

DaShenLin Pharmaceutical Group Co., Ltd. on 6ix

Story so far

Earlier from DaShenLin Pharmaceutical

Later from DaShenLin Pharmaceutical

All DaShenLin Pharmaceutical news releases